Page last updated: 2024-08-16
vorinostat and bl1521
vorinostat has been researched along with bl1521 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Helquist, P; Lan-Hargest, HY; Wang, DF; Wiech, NL; Wiest, O | 1 |
| Knutson, AK; Roy, S; Taylor, T; Tenniswood, M; Wang, WL; Welsh, J | 1 |
Other Studies
2 other study(ies) available for vorinostat and bl1521
| Article | Year |
|---|---|
QSAR studies of PC-3 cell line inhibition activity of TSA and SAHA-like hydroxamic acids.
Topics: Antineoplastic Agents; Cell Division; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Male; Molecular Structure; Prostatic Neoplasms; Quantitative Structure-Activity Relationship; Tumor Cells, Cultured; Vorinostat | 2004 |
Comparative effects of histone deacetylase inhibitors on p53 target gene expression, cell cycle and apoptosis in MCF-7 breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Centrosome; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Genes, p53; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Spindle Apparatus; Tumor Suppressor Protein p53; Vorinostat | 2012 |